MedPath

23ANDME, INC.

23ANDME, INC. logo
๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
Public, Subsidiary
Established
2006-04-01
Employees
501
Market Cap
-
Website
http://www.23andme.com

Study of 23ME-01473 in Patients With Advanced Solid Malignancies

Phase 1
Terminated
Conditions
Solid Tumor
Interventions
Drug: 23ME-01473
First Posted Date
2024-03-04
Last Posted Date
2024-12-04
Lead Sponsor
23andMe, Inc.
Target Recruit Count
5
Registration Number
NCT06290388
Locations
๐Ÿ‡บ๐Ÿ‡ธ

START Midwest, Grand Rapids, Michigan, United States

๐Ÿ‡บ๐Ÿ‡ธ

Oregon Health & Science University, Portland, Oregon, United States

๐Ÿ‡บ๐Ÿ‡ธ

START Center for Cancer Care, San Antonio, Texas, United States

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

Phase 1
Active, not recruiting
Conditions
Clear Cell Renal Cell Carcinoma
Epithelial Ovarian Cancer
MSI-H Cancer
Extensive-stage Small-cell Lung Cancer
Fallopian Tube Cancer
Cancer With A High Tumor Mutational Burden
Solid Tumor
Primary Peritoneal Carcinoma
Neuroendocrine Tumors
Interventions
Drug: 23ME-00610
First Posted Date
2022-01-20
Last Posted Date
2024-11-15
Lead Sponsor
23andMe, Inc.
Target Recruit Count
141
Registration Number
NCT05199272
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Stanford Cancer Institute, Palo Alto, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

R.J.Zuckerberg Cancer Center, Lake Success, New York, United States

๐Ÿ‡บ๐Ÿ‡ธ

Cohen Children's Medical Center, New Hyde Park, New York, United States

and more 10 locations

23andMe IPF Research Study

Completed
Conditions
Idiopathic Pulmonary Fibrosis
Interventions
Other: No intervention
First Posted Date
2021-08-31
Last Posted Date
2024-12-09
Lead Sponsor
23andMe, Inc.
Target Recruit Count
690
Registration Number
NCT05028894
Locations
๐Ÿ‡บ๐Ÿ‡ธ

23andMe, Sunnyvale, California, United States

Web-based Weight Loss Intervention

Not Applicable
Completed
Conditions
Overweight and Obesity
Interventions
Behavioral: Lower carbohydrate diet
Behavioral: Physical activity focused
Behavioral: Higher fiber diet
First Posted Date
2018-01-17
Last Posted Date
2020-06-04
Lead Sponsor
23andMe, Inc.
Target Recruit Count
63656
Registration Number
NCT03400696
Locations
๐Ÿ‡บ๐Ÿ‡ธ

23andMe, Mountain View, California, United States

Web-based Genetic Research on Lupus

Completed
Conditions
Systemic Lupus Erythematosus
First Posted Date
2015-08-21
Last Posted Date
2018-01-10
Lead Sponsor
23andMe, Inc.
Target Recruit Count
5000
Registration Number
NCT02530944
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Www.23Andme.Com/Lupus, Mountain View, California, United States

Web-based Genetic Research on Parkinson's Disease

Completed
Conditions
Parkinson's Disease
First Posted Date
2011-05-11
Last Posted Date
2022-11-03
Lead Sponsor
23andMe, Inc.
Target Recruit Count
13576
Registration Number
NCT01351467
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Www.23Andme.Com/Pd, Mountain View, California, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath